FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

377186003: Antazoline phosphate + naphazoline hydrochloride 5mg/0.5mg solution (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2017. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1202502017 Antazoline phosphate + naphazoline hydrochloride 5mg/0.5mg solution (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1478562017 Antazoline phosphate+naphazoline hydrochloride 5mg/0.5mg solution en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1202502017 Antazoline phosphate + naphazoline hydrochloride 5mg/0.5mg solution (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1202502017 Antazoline phosphate + naphazoline hydrochloride 5mg/0.5mg solution (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1215413019 Antazoline phosphate + naphazoline hydrochloride 5mg/0.5mg solution en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1478562017 Antazoline phosphate+naphazoline hydrochloride 5mg/0.5mg solution en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1478562017 Antazoline phosphate+naphazoline hydrochloride 5mg/0.5mg solution en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Antazoline phosphate + naphazoline hydrochloride 5mg/0.5mg solution Is a Antazoline phosphate (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Antazoline phosphate + naphazoline hydrochloride 5mg/0.5mg solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Antazoline phosphate (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Antazoline phosphate + naphazoline hydrochloride 5mg/0.5mg solution Is a Antazoline phosphate + naphazoline hydrochloride false Inferred relationship Existential restriction modifier (core metadata concept)
    Antazoline phosphate + naphazoline hydrochloride 5mg/0.5mg solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Naphazoline hydrochloride (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Antazoline phosphate + naphazoline hydrochloride 5mg/0.5mg solution Has manufactured dose form Ocular dose form (dose form) false Inferred relationship Existential restriction modifier (core metadata concept)
    Antazoline phosphate + naphazoline hydrochloride 5mg/0.5mg solution Is a Product containing naphazoline in ophthalmic dosage form false Inferred relationship Existential restriction modifier (core metadata concept)
    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator attribute value reference set (foundation metadata concept)

    Back to Start